USA flag logo/image

An Official Website of the United States Government

XRpro Technology for the Detection and Evaluation of Carcinogens

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
95907
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
CA150404
Solicitation Year:
N/A
Solicitation Topic Code:
NCI
Solicitation Number:
N/A
Small Business Information
Caldera Pharmaceuticals, Inc.
278 DP Road Suite D LOS ALAMOS, NM -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: XRpro Technology for the Detection and Evaluation of Carcinogens
Agency: HHS
Contract: 1R43CA150404-01
Award Amount: $200,000.00
 

Abstract:

DESCRIPTION (provided by applicant): Caldera Pharmaceuticals will develop quantitative biomarker assays for a set of carcinogens. In Phase I, Caldera will demonstrate the feasibility of using its novel XRpro(R) technology to extract, concentrate, quantify, and characterize carcinogens from biological samples. This will also identify protein adduct biomarkers that are involved in critical carcinogenic and biotransformation pathways. This project addresses challenges listed in PA-09-187, including the measure ment of carcinogens directly, without antibodies, dyes, tags, or radioactive materials. PUBLIC HEALTH RELEVANCE: Caldera Pharmaceuticals will develop quantitative biomarker assays for a set of carcinogens. This project addresses challenges listed in PA-09-187, including the measurement of carcinogens directly, without antibodies, dyes, tags, or radioactive materials.

Principal Investigator:

Benjamin P. Warner
5054122345
WARNER@CALDERA-PHARMACEUTICALS.COM

Business Contact:


court@cpsci.com
Small Business Information at Submission:

CALDERA PHARMACEUTICALS, INC.
278 DP Road Suite D LOS ALAMOS, NM 87544

EIN/Tax ID: 120098206
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No